300255.SZ Stock Analysis
30
Uncovered
Hebei Changshan Biochemical Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of heparin active pharmaceutical ingredient (API) and heparin preparations. The company is headquartered in Shijiazhuang, Hebei and currently employs 1,306 full-time employees. The company went IPO on 2011-08-19. The firm primarily provides heparin product series. The firm provides sodium heparin active pharmaceutical ingredients (APIs) and hydro-acupuncture preparations. The firm's products are applied primarily in the prevention and treatment of cerebral vascular diseases, hardened arteries, myocardial infarction and phlebitis, among others. The company distributes its products in domestic and overseas markets.